Elizabeth R. Handorf
Elizabeth R. Handorf publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Multiple and Secondary Primary Cancers, Renal cell carcinoma treatment and Bladder and Urothelial Cancer Treatments.
- World rank
- #6,129,995 of 7,710,434 ranked researchers
- Rank in United States
- #1,479,510 of 1,627,098
- Works
- 76
- Citations
- 490
- Citations per work
- 6.4
What does Elizabeth R. Handorf research?
Elizabeth R. Handorf's work is mostly in Medicine (67%), Economics, Econometrics and Finance (4%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5167.2%
- Medicine5167.2%
- Everything else1925.2%
- Social Sciences34.3%
- Life Sciences33.3%
- 1Pulmonary and Respiratory Medicine23% of their works
- 2Oncology19% of their works
- 3Surgery18% of their works
- 4Epidemiology8% of their works
- 5Economics and Econometrics4% of their works
- 6Cancer Research3% of their works
Research topics
- Multiple and Secondary Primary Cancers
- Renal cell carcinoma treatment
- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Pancreatic and Hepatic Oncology Research
- Global Cancer Incidence and Screening
- Economic and Financial Impacts of Cancer
Which keywords describe Elizabeth R. Handorf's research?
The keywords of their largest research topics: Immunotherapy, Molecular Characterization, Clinical Guidelines, Genetic Mutations, Cancer Incidence, Population-Based Study, Chemotherapy and Neoadjuvant Therapy.
- Global Surveillance
- Cost of Care
- Pancreatic Cancer
- Radiation Therapy
- Androgen Receptor
- Bladder Cancer
- Metastatic
- Multiple Primary Cancers
- Neoadjuvant Therapy
- Population-Based Study
- Genetic Mutations
- Molecular Characterization
- Immunotherapy
- Clinical Guidelines
- Cancer Incidence
- Chemotherapy
- Prostate Cancer
- Second Primary Neoplasms
- Renal Cell Carcinoma
- Urothelial Carcinoma
- Genomic Profiling
- Screening
- Surgical Complications
- Financial Toxicity
- Mortality Rates
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Immunotherapy394 topics
- Molecular Characterization222 topics
- Clinical Guidelines212 topics
- Genetic Mutations212 topics
- Cancer Incidence202 topics
- Population-Based Study202 topics
- Chemotherapy182 topics
- Neoadjuvant Therapy182 topics
- Prostate Cancer182 topics
- Multiple Primary Cancers131 topic
- Second Primary Neoplasms131 topic
- Metastatic121 topic
- Renal Cell Carcinoma121 topic
- Bladder Cancer101 topic
- Urothelial Carcinoma101 topic
- Androgen Receptor91 topic
- Genomic Profiling91 topic
- Radiation Therapy91 topic
- Screening91 topic
- Pancreatic Cancer81 topic
- Surgical Complications81 topic
- Cost of Care71 topic
- Financial Toxicity71 topic
- Global Surveillance71 topic
- Mortality Rates71 topic
Where does Elizabeth R. Handorf work?
Elizabeth R. Handorf's main affiliation in the publication record is Fox Chase Cancer Center, United States.
How many publications and citations does Elizabeth R. Handorf have?
OpenAlex counts 76 works and 490 citations for Elizabeth R. Handorf, an h-index of 14, ranking #6,129,995 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Elizabeth R. Handorf. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.